妇产科指南

订阅

MedSci主页 / 所有栏目 / 妇产科指南

2021 SOGC临床实践指南：更年期和乳腺癌（No.422f）

2021-12-04 加拿大妇产科医生协会 J Obstet Gynaecol Can

乳腺癌更年期

2021年12月，加拿大妇产科医生协会(SOGC)发布了更年期和乳腺癌指南。本文依据最新证据，提供了改善围绝经期和绝经期后女性的护理策略。

中文标题：

2021 SOGC临床实践指南：更年期和乳腺癌（No.422f）

英文标题：

Guideline No. 422f: Menopause and Breast Cancer

发布机构：

加拿大妇产科医生协会

发布日期：

2021-12-04

简要介绍：

2021年12月，加拿大妇产科医生协会(SOGC)发布了更年期和乳腺癌指南。本文依据最新证据，提供了改善围绝经期和绝经期后女性的护理策略。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 SOGC临床实践指南：更年期和乳腺癌（No.422f）.pdf)] GetToolGuiderByIdResponse(projectId=1, id=3b05a1c0022915f6, title=2021 SOGC临床实践指南：更年期和乳腺癌（No.422f）, enTitle=Guideline No. 422f: Menopause and Breast Cancer, guiderFrom=J Obstet Gynaecol Can, authorId=0, author=, summary=2021年12月，加拿大妇产科医生协会(SOGC)发布了更年期和乳腺癌指南。本文依据最新证据，提供了改善围绝经期和绝经期后女性的护理策略。, cover=https://img.medsci.cn/20211215/1639574538993_1608702.png, journalId=0, articlesId=null, associationId=155, associationName=加拿大妇产科医生协会, associationIntro=加拿大妇产科医生协会成立于1944年，它的使命是通过领导、宣传、合作、宣传和教育推进妇女健康，促进妇产科发展卓越。专业期刊有Journal&nbsp;of Obstetrics and Gynaecology Canada (JOGC), copyright=0, guiderPublishedTime=Sat Dec 04 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2021年12月，加拿大妇产科医生协会(SOGC)发布了更年期和乳腺癌指南。本文依据最新证据，提供了改善围绝经期和绝经期后女性的护理策略。</span></p>, tagList=[TagDto(tagId=285, tagName=乳腺癌), TagDto(tagId=1561, tagName=更年期)], categoryList=[CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=6, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6325, appHits=59, showAppHits=0, pcHits=312, showPcHits=6265, likes=0, shares=4, comments=7, approvalStatus=1, publishedTime=Wed Dec 15 21:20:35 CST 2021, publishedTimeString=2021-12-04, pcVisible=1, appVisible=1, editorId=1608702, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=dajiong, createdTime=Wed Dec 15 21:26:55 CST 2021, updatedBy=1608702, updatedName=dajiong, updatedTime=Thu Jan 04 15:59:40 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 SOGC临床实践指南：更年期和乳腺癌（No.422f）.pdf)])
2021 SOGC临床实践指南：更年期和乳腺癌（No.422f）.pdf
下载请点击：
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1183563, encodeId=35ad1183563b2, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c526402168, createdName=ms5000000686165165, createdTime=Wed Jan 12 16:49:09 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083320, encodeId=e7d01083320c2, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Dec 22 23:50:48 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081021, encodeId=92d01081021c8, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce4e5648827, createdName=ms2000000029362486, createdTime=Fri Dec 17 08:07:26 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080506, encodeId=84a61080506d0, content=嘎嘎嘎嘎, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Thu Dec 16 07:01:14 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080497, encodeId=18da108049e8e, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Thu Dec 16 06:59:47 CST 2021, time=2021-12-16, status=1, ipAttribution=)]
    2022-01-12 ms5000000686165165

    学习学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1183563, encodeId=35ad1183563b2, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c526402168, createdName=ms5000000686165165, createdTime=Wed Jan 12 16:49:09 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083320, encodeId=e7d01083320c2, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Dec 22 23:50:48 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081021, encodeId=92d01081021c8, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce4e5648827, createdName=ms2000000029362486, createdTime=Fri Dec 17 08:07:26 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080506, encodeId=84a61080506d0, content=嘎嘎嘎嘎, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Thu Dec 16 07:01:14 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080497, encodeId=18da108049e8e, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Thu Dec 16 06:59:47 CST 2021, time=2021-12-16, status=1, ipAttribution=)]
    2021-12-22 一己怀

    学习学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1183563, encodeId=35ad1183563b2, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c526402168, createdName=ms5000000686165165, createdTime=Wed Jan 12 16:49:09 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083320, encodeId=e7d01083320c2, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Dec 22 23:50:48 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081021, encodeId=92d01081021c8, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce4e5648827, createdName=ms2000000029362486, createdTime=Fri Dec 17 08:07:26 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080506, encodeId=84a61080506d0, content=嘎嘎嘎嘎, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Thu Dec 16 07:01:14 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080497, encodeId=18da108049e8e, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Thu Dec 16 06:59:47 CST 2021, time=2021-12-16, status=1, ipAttribution=)]
    2021-12-17 ms2000000029362486

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1183563, encodeId=35ad1183563b2, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c526402168, createdName=ms5000000686165165, createdTime=Wed Jan 12 16:49:09 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083320, encodeId=e7d01083320c2, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Dec 22 23:50:48 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081021, encodeId=92d01081021c8, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce4e5648827, createdName=ms2000000029362486, createdTime=Fri Dec 17 08:07:26 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080506, encodeId=84a61080506d0, content=嘎嘎嘎嘎, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Thu Dec 16 07:01:14 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080497, encodeId=18da108049e8e, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Thu Dec 16 06:59:47 CST 2021, time=2021-12-16, status=1, ipAttribution=)]
    2021-12-16 微探

    嘎嘎嘎嘎

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1183563, encodeId=35ad1183563b2, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c526402168, createdName=ms5000000686165165, createdTime=Wed Jan 12 16:49:09 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083320, encodeId=e7d01083320c2, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Dec 22 23:50:48 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081021, encodeId=92d01081021c8, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce4e5648827, createdName=ms2000000029362486, createdTime=Fri Dec 17 08:07:26 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080506, encodeId=84a61080506d0, content=嘎嘎嘎嘎, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Thu Dec 16 07:01:14 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080497, encodeId=18da108049e8e, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Thu Dec 16 06:59:47 CST 2021, time=2021-12-16, status=1, ipAttribution=)]
    2021-12-16 微探

    学习学习

    0

相关指南

大数据时代乳腺癌精准诊疗模式现状研究

国家癌症中心 · 2021-11-01

《HR _HER2-转移性乳腺癌患者内分泌治疗和靶向治疗：ASCO更新版指南》解读

武汉大学中南医院放化疗科 · 2021-10-30

乳腺癌患者的营养治疗专家共识

中国抗癌协会肿瘤营养专业委员会 · 2021-08-09

FDA指导原则：pCR作为高风险早期乳腺癌新辅助治疗终点加速药物研发

美国食品和药品监督管理局(FDA,Food and Drug Administration) · 2021-10-01

中国抗癌协会乳腺癌诊治指南与规范（2021年版）

中国抗癌协会乳腺癌专业委员会(CACA-CBCS,Chinese Anti-Cancer Association, Committee of Breast Cancer Society) · 2021-08-30

2021 SITC临床实践指南：乳腺癌的免疫治疗

肿瘤免疫治疗学会(SITC,Society for Immunotherapy of Cancer) · 2021-08-09